SC002: Clinical Trials

1 trial of SC002, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow SC002: new trials by email Literature Review of SC002 trials Research Report on SC002

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
SC-002 - Small Cell Lung Cancer
Phase 1TerminatedStemcentrx352015-06-012018-10-05

Conditions studied

Small Cell Lung Carcinoma (1)

Sponsors

Stemcentrx (1)

Countries

United States (1)

Top investigators

Julia Lawrence, D.O. (1)

Results publications

PMID 32438272